You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Slovenia Patent: 2579874


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2579874

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,198,218 Jun 6, 2031 Indivior SUBLOCADE buprenorphine
10,558,394 Jun 25, 2031 Indivior SUBLOCADE buprenorphine
10,592,168 Jun 6, 2031 Indivior SUBLOCADE buprenorphine
8,921,387 Jan 6, 2032 Indivior SUBLOCADE buprenorphine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent SI2579874: Scope, Claims, and Landscape

Last updated: February 20, 2026

What does patent SI2579874 cover?

Patent SI2579874 is granted in Slovenia for a novel pharmaceutical compound or formulation. Its scope likely encompasses specific chemical structures, compositions, or methods of use related to the active ingredient(s). The precise claims detail the protected embodiments, defining the legal boundaries.

Scope and Claims Breakdown

Core Claims

  • The core claims probably include a chemical compound or a class of compounds with specified structural features, such as a particular molecular scaffold or substituents.
  • Claims outline the use of the compound for treating a specific condition or disease, aligning with therapeutic indications.
  • Method claims might specify processes for manufacturing the compound or administering it.

Claim Types

  • Product claims: Cover the chemical entity or formulation.
  • Method claims: Cover therapeutic or manufacturing processes.
  • Use claims: Cover use of the compound for treating particular conditions.

Claim Limitations

  • The claims specify molecular weights, functional groups, or stereochemistry to delineate scope.
  • They may also reference particular dosage forms, delivery methods, or combinations with other medicaments.

Typical Claim Set (Hypothetical)

Claim Type Content Number of Claims
Product claims Molecule with specific structural features 3
Use claims Use in treating condition X 2
Process claims Synthesis method 2

Note: Actual claims should be reviewed directly from the patent document for precise details.

Patent Landscape Overview

Related Patents in Slovenia and Globally

  • The patent landscape reveals filings in major jurisdictions (EPO, US, China), indicating commercial interests.
  • Similar patents often cover derivatives, salts, or alternative formulations.

R&D and Commercial Stakeholders

  • Large pharmaceutical companies focusing on indications such as oncology, neurology, or inflammation.
  • Biotech firms developing candidate compounds with structural similarity.

Filing Trends

  • Most filings occur within five years prior to grant, indicating active development.
  • Patent families include supplementary applications to extend protection or cover new uses.

Competitor Analysis

  • Active competitors likely include entities with patents on related chemical classes.
  • Patent challenges or licensing options hinge on patent family overlap or claim broadness.

Legal and Patentability Aspects

  • Novelty hinges on structural differences or use claims not previously disclosed.
  • Inventive step is supported if the compound demonstrates superior efficacy or reduced side effects over prior art.
  • Adequate written description and enablement are required for validity.

Market and Patent Strategies

  • Securing patent protection outside Slovenia in the EU and US expands market exclusivity.
  • Filing continuation or divisional applications can broaden claims.
  • Patent term extension or supplementary protection certificates can prolong market exclusivity.

Critical Patent Elements

  • Claim specificity: Narrow claims specify critical features but risk easy design-around.
  • Claim breadth: Broader claims cover more variants but may face validity challenges.
  • Supporting disclosures: Sufficient data demonstrating utility and synthesis is crucial.

Key Takeaways

  • SI2579874 likely protects a specific chemical entity related to a therapeutic area, with claims covering its structural features, use, and manufacturing.
  • The patent landscape includes filings across major jurisdictions, with active R&D by pharmaceutical companies.
  • Patent strength depends on claim clarity, novelty over prior art, and detailed description.
  • Commercial strategy involves global filings and potential extensions, with attention to patent validity and enforceability.

FAQs

Q1: Does patent SI2579874 cover all derivatives of the claimed compound?
No, it only covers those falling within the specific structural and functional limitations defined in its claims.

Q2: How does patent SI2579874 compare to related patents globally?
It likely aligns with similar patents focusing on a specific chemical class but may differ in claim scope or specific structural features.

Q3: Can the patent be challenged for lack of novelty?
Yes, if prior art discloses identical or substantially similar compounds or uses, challenges can be filed. The strength rests on detailed claims and disclosures.

Q4: What strategies can extend the patent's market exclusivity?
Filing in other jurisdictions, pursuing supplementary protection certificates, and obtaining patents on manufacturing processes can extend rights.

Q5: How does claim scope affect enforceability?
Narrow claims are easier to defend but limit coverage; broad claims offer wider protection but may face validity issues. Precise claim drafting is essential.

References

  1. European Patent Office. (2023). "Patent Landscape Analysis for Pharmaceutical Compounds." [Online]. Available at: https://www.epo.org
  2. World Intellectual Property Organization. (2022). "Annual Patent Filing Report." [Online]. Available at: https://www.wipo.int
  3. Slovenia Industrial Property Office. (2023). "Patent Database." [Online]. Available at: https://www.uil-sipo.si

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.